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Abstract: 
Introduction: Antisperm antibody (ASA) in men cause autoimmune disease, respectively, immune infertility. DNA 
fragmentation is the separation or breaking of DNA strands in pieces. DNA fragmentation testing is a type of male 
fertility test that measures the percentage of damaged DNA in a sperm sample. 
Aim:  The purpose of this study was to detect the presence of ASA and their incidence in male infertility with 
unknown etiology, as well as to evaluate the correlation between ASA and the percentage of sperm DNA 
fragmentation. 
Methods: The study included 61 men with unknown infertility and 39 males control. Evaluation of the presence of 
antisperm antibody in the semen resulted in a direct mixed anti globulin (MAR) reaction and sperm DNA 
fragmentation with the Halosperm Halotech DNA, Madrid, Spain, test based on SCD technique, based on DNA-
denatured. 
Results: In the MAR test, 21.68 % of infertile men with unknown etiology were positive for ASA. Only one case was 
found in fertile male with positive ASA. Results of the DNA fragmentation index (DFI %) did not have a positive 
correlation with the ASA presence percentage in patients with positive test MAR. 
Conclusions: Results show that antisperm antibody (ASA) are involved in decreased fertility in vivo conditions in 
patients with positive test MAR. DNA Fragmentation Index Results (% DFI %) did not show genetic damage to the 
spermatozoa in these cases with immune infertility. 
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Antisperm antibody are antibodies produced 
against sperm cells antigens [1]. ASA has been 
considered as infertility cause in around 10–30% of 
infertile couples, and in males, about 12–13% [2]. All 
infertility diagnosed to date is linked to an 
immunological reason. The incidence may be higher, 
as the contribution to idiopathic infertility (31% of all 
cases) remains incomprehensible. The presence of 
ASA in the fertile population suggests that not all 
ASAs cause infertility [3]. Risk factors for the 
formation of antisperm antibody in men include the 
breakdown of the blood‑testis barrier, trauma, and 
surgery, orchitis [4], varicocele [5], infections, 
prostatitis, testicular cancer [6]. In both men and 
women, ASA production is directed against 
superficial sperm antigens that may interfere with 
sperm movement, transport through female 
reproductive tract, curbing the capacity and reaction 
of acrosomes, damaged fertilization, impact on the 
process the implantation and the growth and 
development of the affected embryo [7]. The 
antibodies can damage or kill sperm. If a high 
number of sperm antibodies come into contact with a 
man's sperm, it may be hard for the sperm to fertilize 
an egg. This is called immunologic infertility. 
Antisperm antibodies directed against sperm did not 
necessarily impair fertility unless the circulating 
antibodies are also present within the reproductive 
tract and on the living sperm surface [8]. Such 
analysis is based on the fact that sperm parameters, 
such as sperm concentration, motility, and 
morphology, have been shown to be closely related to 
the degree of pregnancy. This because it is a cost-
effective and non-invasive test has led to the 
widespread use of sperm analysis in the initial 
assessment of infertile males [9]. Criteria for normal 
sperm parameters vary according to the WHO lab 
manuals for human sperm examination and 
processing [10]. Sperm analysis does not give 
information about defects in the sperm. Men's 
assessment of fertility should go far beyond sperm 
counting and assessment of mobility and 
morphology. It should be supplemented by a proper 
clinical examination, history, hormonal analysis (fsh, 
lh, prol, test), genetic analysis, sperm DNA 
fragmentation, etc. [11]. Formation of anti-sperm 
antibodies is reported in 42% of males with 
unexplained infertility, 10.7% of males subject to 
infertility estimates, 10% of males in pairs subject to 
IVF treatment, but only in 2% of fertile men. 
Moreover, sperm contains several substances that 
inhibit the complement system of activation elements 
required by immobilizing and apoptogenic ASAs [12, 
13].  Therefore, finding normal sperm parameters in 
men with immune infertility is a common occurrence. 
Additional factors associated with altered DNA 
integrity include advanced paternal age, inadequate 
diet, drug abuse, tobacco use, environmental factors 
such as pesticide exposure or air pollution, 
varicocele, systemic diseases, and genital 
inflammation [14]. Studies have linked DNA damage 
with infertility, showing greater DNA damage in the 
sperm of infertile men than of fertile men [15, 16].  In 
fact, it has been suggested that sperm DNA 
fragmentation is one of the chief causes of reduced 
fertility potential. The DNA damage is reported in 5-
8% of infertile normozoospermic men [17].  
 
Purpose of the work: 
The purpose of this study was to detect the presence 
of ASA and their incidence in male infertility with 
unknown etiology, as well as to evaluate the 
correlation between ASA and the percentage of 
sperm DNA fragmentation. All the participants in 
the study were from the Republic of Kosovo. The 
statistical processing of the data is done with the 
statistical package SPSS 22.0.  The level of 
significance was set at P < 0.05. 
 
MATERIALS AND METHODS: 
The study included 61 men with unknown infertility 
and 39 males control. Evaluation of the presence of 
antisperm antibody in the semen resulted in a direct 
mixed antiglobulin (MAR) reaction and sperm DNA 
fragmentation with the Halosperm Halotech DNA, 
Madrid, Spain, test based on SCD technique, based 
on DNA-denatured.  
 
Sperm analysis was done according to WHO 2010 
recommendations, manual V. 
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Foto 2. The working reagent for the Sperm DNA fragmentation assay, and how is a normal DNA fragmentation 
analysis in spermatozoa. 
 
Foto 3. Analysis of DNA fragmentation in spermatozoa with positive test MAR. 
  
Our results show that positive MAR tests did not affect DNA damage to the sperm. 
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Table 1. Semen analyses (macroscopic and 
microscopic),  antisperm antibodies test (MAR test) 
and Sperm DNA fragmentation (%) in fertile and 
infertile men. 
  
In the MAR test, 21.68 % of infertile men with 
unknown etiology were positive for ASA. Only one 
case was found in fertile male with positive ASA. 
Results of the DNA fragmentation index (DFI %) did 
not have a positive correlation with the ASA presence 
percentage in patients with positive test MAR. 
 
DISCUSSION: 
Antisperm antibodies can affect adversely human 
fertility but normally may be controlled by anti-
idiotypic antibodies which along with immune 
suppressor factors in semen prevent their induction to 
a significant degree. This balance between the 
detrimental and “beneficial” immune response to 
sperm may be shifted towards an antisperm antibody 
response by stimulatory factors such as infection [18]. 
Michael S Cookson et al 1995 [19], performed 
retrospective study to evaluate the ability to predict 
sperm surface antisperm antibody in patients with 
primary infertility on the basis of impaired sperm 
motility. He reviewed seminal characteristics of 70 
consecutive ASA positive infertility patients & found 
patients with lower motilities were significantly ASA 
positive (P=0.016) as compared to patients with sperm 
concentrations of >20 million/ml (P=0.002) therefore, 
the impaired motility was significantly associated in 
ASA positive patients. So it is concluded that although 
the difference in the incidence of ASA in primary & 
secondary infertility is not statistically significant, its 
detection can provide a clue to the aetiologic factor in 
such couples. Immunoglobulin’s A (IgA) and G (IgG) 
classes are functionally important antibodies to male 
infertility as IgM has high molecular weight and can 
not penetrate the blood barrier. These antibodies are 
associated with sperm and decrease the ability of 
fertilization. Clark et al., Showed a 27% fertilization 
rate when ≥ 80% of the sperm contained IgA and IgG-
related sperm while the 72% fertilization rate was seen 
when ≤ 80% of sperm had ASA-related spermatozoa 
[20].  It is not clear whether the location of the 
associated semen, whether the head of the sperm or the 
tail, is ASA, since there are contradictory reports that 
estimate the localization value and its correlation with 
the fertilization capacity [21]. ASA has the ability to 
damage some of the stages of the fertilization process. 
Filling in the cervix of the cervix can be associated 
with antibodies and cause sperm lysis, reducing 
mobility and preventing sperm's ability to penetrate 
cervical mucus [22, 23].  Evidence suggests that ASA 
affects sperm to have lower rates of spontaneous 
reaction and cause acrosome damage [24, 25]. Some 
ASAs have also shown that they inhibit the 
spontaneous response of sperm capacity, and have 
been provided to suggest that ASA may interfere with 
the recognition of sperm-associated sites in the 
pellucid area [21]. High percentages of DNA damage 
to the sperm have a negative impact on the human 
ability to reach pregnancy naturally and relate to 
spontaneous loss of pregnancy [26, 27]. It has also 
been shown that the high rate of DNA damage in the 
sperm is related to the failure to fertilize intrauterine 
(IUI) [28], and IVF [29, 30], but not ICSI [30].  
CONCLUSIONS: 
Sperm routine analysis does not guarantee fertility. 
This data is important for all clinicians in charge of 
medically assisted medicine involved in the 
management of infertile males. Proper knowledge of 
the in vivo process of human fertilization and the 
interaction of sperm eggs in vitro is key to predicting 
functional changes of spermatozoa with extraordinary 
influence in the diagnosis and treatment of male 
infertility. In our study, we have not found that ASA 
has affected DNA fragmentation in the sperm. MAR 
test, a mixed antiglobulin reaction (test MAR), using 
red cells coated with antibody and sperm, was used to 
detect the presence of IgA or IgG on the surface of the 
sperm. Positive MAR (IgA) tests showed a very 
significant correlation with the presence of anti-sperm 
antibodies in the seminal plasma. We recommend the 
testing of ASA and sperm DNA fragmentation in 
infertile couples, where infertility causes are males. 
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